Michael L Blute, MD | |
15 Parkman St, Wang 528, Boston, MA 02114-3117 | |
(617) 726-4530 | |
(617) 726-6131 |
Full Name | Michael L Blute |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 42 Years |
Location | 15 Parkman St, Boston, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437120037 | NPI | - | NPPES |
219720100 | Medicaid | MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 27812 (Minnesota) | Secondary |
208800000X | Urology | 242751 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Partners Healthcare At Home - Home Care | Waltham, MA | Home health agency |
Massachusetts General Hospital | Boston, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
News Archive
Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) have identified a potential therapeutic strategy to treat Alzheimer's, according to a study published in Journal of Neuroscience.
It's no secret that long-distance, west-to-east air travel - Seattle to Paris, for example - can raise havoc with a person's sleep and waking patterns, and that the effects are substantially less pronounced when traveling in the opposite direction.
The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.
BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint in the Phase 3 clinical study of Clonidine Topical Gel compared to placebo for the treatment of painful diabetic neuropathy did not meet statistical significance, although certain secondary endpoints showed statistically significant improvement over placebo. In addition, a strong safety profile for the product was observed.
New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, including inflammation and genetic damage that could indicate long-term risk for respiratory disease and even cancer.
› Verified 2 days ago
Entity Name | Massachusetts General Physicians Organization Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) have identified a potential therapeutic strategy to treat Alzheimer's, according to a study published in Journal of Neuroscience.
It's no secret that long-distance, west-to-east air travel - Seattle to Paris, for example - can raise havoc with a person's sleep and waking patterns, and that the effects are substantially less pronounced when traveling in the opposite direction.
The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.
BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint in the Phase 3 clinical study of Clonidine Topical Gel compared to placebo for the treatment of painful diabetic neuropathy did not meet statistical significance, although certain secondary endpoints showed statistically significant improvement over placebo. In addition, a strong safety profile for the product was observed.
New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, including inflammation and genetic damage that could indicate long-term risk for respiratory disease and even cancer.
› Verified 2 days ago
Entity Name | The General Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) have identified a potential therapeutic strategy to treat Alzheimer's, according to a study published in Journal of Neuroscience.
It's no secret that long-distance, west-to-east air travel - Seattle to Paris, for example - can raise havoc with a person's sleep and waking patterns, and that the effects are substantially less pronounced when traveling in the opposite direction.
The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.
BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint in the Phase 3 clinical study of Clonidine Topical Gel compared to placebo for the treatment of painful diabetic neuropathy did not meet statistical significance, although certain secondary endpoints showed statistically significant improvement over placebo. In addition, a strong safety profile for the product was observed.
New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, including inflammation and genetic damage that could indicate long-term risk for respiratory disease and even cancer.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Michael L Blute, MD Po Box 9142, Charlestown, MA 02129-9142 Ph: () - | Michael L Blute, MD 15 Parkman St, Wang 528, Boston, MA 02114-3117 Ph: (617) 726-4530 |
News Archive
Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro) have identified a potential therapeutic strategy to treat Alzheimer's, according to a study published in Journal of Neuroscience.
It's no secret that long-distance, west-to-east air travel - Seattle to Paris, for example - can raise havoc with a person's sleep and waking patterns, and that the effects are substantially less pronounced when traveling in the opposite direction.
The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.
BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint in the Phase 3 clinical study of Clonidine Topical Gel compared to placebo for the treatment of painful diabetic neuropathy did not meet statistical significance, although certain secondary endpoints showed statistically significant improvement over placebo. In addition, a strong safety profile for the product was observed.
New research appearing in the journal Scientific Reports unpacks the list of chemicals that comprise flavored e-liquids and pods used in vaping and details their harmful effects to lung tissue, including inflammation and genetic damage that could indicate long-term risk for respiratory disease and even cancer.
› Verified 2 days ago
Brian Howard Eisner, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-3512 | |
Catherine Gu, MD Urology Medicare: Not Enrolled in Medicare Practice Location: Bwh 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 | |
Dr. Dianne E Sacco, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Dept Of Urology, Boston, MA 02114 Phone: 617-726-3760 Fax: 617-726-6131 | |
Peter Lang Steinberg, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Bidmc Division Of Urology, Rabb 440, Boston, MA 02215 Phone: 617-667-3739 | |
Richard N Yu, M.D, PH.D. Urology Medicare: May Accept Medicare Assignments Practice Location: 300 Longwood Ave, Department Of Urology, Hu-390, Boston, MA 02115 Phone: 617-355-7796 | |
Dr. Quoc-dien Trinh, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 45 Francis St, Division Of Urology, Boston, MA 02115 Phone: 617-525-7350 | |
Dr. Melise A Keays, MD Urology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 |